181 related articles for article (PubMed ID: 9568638)
1. Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells.
Ree AH; Bjørnland K; Brünner N; Johansen HT; Pedersen KB; Aasen AO; Fodstad O
Clin Exp Metastasis; 1998 Apr; 16(3):205-15. PubMed ID: 9568638
[TBL] [Abstract][Full Text] [Related]
2. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
3. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness.
Johnson MD; Torri JA; Lippman ME; Dickson RB
Exp Cell Res; 1999 Feb; 247(1):105-13. PubMed ID: 10047452
[TBL] [Abstract][Full Text] [Related]
4. Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer.
Castelló R; Estellés A; Vázquez C; Falcó C; España F; Almenar SM; Fuster C; Aznar J
Clin Chem; 2002 Aug; 48(8):1288-95. PubMed ID: 12142386
[TBL] [Abstract][Full Text] [Related]
5. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression.
Martens JW; Sieuwerts AM; Bolt-deVries J; Bosma PT; Swiggers SJ; Klijn JG; Foekens JA
Thromb Haemost; 2003 Feb; 89(2):393-404. PubMed ID: 12574821
[TBL] [Abstract][Full Text] [Related]
6. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
Abe T; Mori T; Kohno K; Seiki M; Hayakawa T; Welgus HG; Hori S; Kuwano M
Clin Exp Metastasis; 1994 Jul; 12(4):296-304. PubMed ID: 8039304
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity.
Farina AR; Coppa A; Tiberio A; Tacconelli A; Turco A; Colletta G; Gulino A; Mackay AR
Int J Cancer; 1998 Mar; 75(5):721-30. PubMed ID: 9495240
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.
Brünner N; Boulay V; Fojo A; Freter CE; Lippman ME; Clarke R
Cancer Res; 1993 Jan; 53(2):283-90. PubMed ID: 8380254
[TBL] [Abstract][Full Text] [Related]
9. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
Ellerbroek SM; Hudson LG; Stack MS
Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
[TBL] [Abstract][Full Text] [Related]
10. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
11. Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression.
Ree AH; Maelandsmo GM; Fodstad O
Clin Exp Metastasis; 1996 Sep; 14(4):381-8. PubMed ID: 8878412
[TBL] [Abstract][Full Text] [Related]
12. Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression.
Park SY; Jin ML; Kim YH; Lee SJ; Park G
Oncol Rep; 2014 Jan; 31(1):497-504. PubMed ID: 24220687
[TBL] [Abstract][Full Text] [Related]
13. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
14. Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells.
Bjørnland K; Lehne G; Johansen HT; Fodstad O; Rugstad HE; Aasen AO; Ree AH
Oncol Res; 1998; 10(5):255-62. PubMed ID: 9802060
[TBL] [Abstract][Full Text] [Related]
15. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
16. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
17. Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells.
Korem S; Resnick MB; Kraiem Z
J Clin Endocrinol Metab; 1999 Sep; 84(9):3322-7. PubMed ID: 10487706
[TBL] [Abstract][Full Text] [Related]
18. Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
Chao CY; Lii CK; Hsu YT; Lu CY; Liu KL; Li CC; Chen HW
Carcinogenesis; 2013 Aug; 34(8):1843-51. PubMed ID: 23615401
[TBL] [Abstract][Full Text] [Related]
19. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
[TBL] [Abstract][Full Text] [Related]
20. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.
Denkert C; Siegert A; Leclere A; Turzynski A; Hauptmann S
Clin Exp Metastasis; 2002; 19(1):79-85. PubMed ID: 11918086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
